Does hormone-modulating therapy for breast cancer treatment affect risk for Alzheimer disease and related dementias?

FHS
July 19, 2024
9:14 am

The association between hormone-modulating therapy (HMT) for breast cancer treatment and the risk of developing Alzheimer’s disease and related dementias.

How hospitals are grappling with the IV fluid shortage wrought by Hurricane Helene

Hospitals across the country are struggling to conserve and stretch their supplies of IV fluids in the wake of a shortage brought on by Hurricane

October 9, 2024

Multiple Societal Factors Contribute to High HIV Risk in Transgender Women

Homelessness, violence, incarceration, and socioeconomic discrimination are linked to a high risk of HIV in transgender women, according to the CDC’s National HIV Behavioral Surveillance

January 26, 2024

Vir antibody drug aimed at influenza A fails in clinical trial

Vir Biotechnology said Thursday that a long-acting antibody drug designed to protect healthy individuals from influenza A failed to do so in a nearly 3,000-person

July 20, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.